Embera NeuroTherapeutics Seals $4.5M
Embera NeuroTherapeutics Inc. has added $4.5 million in Series A financing from investors including Louisiana Ventures, Louisiana Fund I and Themelios Ventures. The company is developing treatments for smoking cessation and other addictions, and will use the money for preclinical development.
15 August 2011•3 mins read
